Icon

ABSORICA LD (nda211913)- (8MG,16MG,20MG,24MG,28MG,32MG)

ISOTRETINOIN SUN PHARM
8MG,16MG,20MG,24MG,28MG,32MG
No Yes
2035-Aug-04 Expired
None None
None No
ABSORICA LD is retinoids indicated for the treatment of severe recalcitrant nodular acne in non-pregnant patients 12 years of age and older with multiple inflammatory nodules with a diameter of 5 mm or greater. Because of significant adverse reactions associated with its use, ABSORICA LD is reserved for patients with severe nodular acne who are unresponsive to conventional therapy, including systemic antibiotics.
0 0 0
Total Other Developers 4
Drugs with Suitability No
8MG ** ** - - -
16MG ** ** - - -
20MG ** ** - - -
24MG ** ** - - -
28MG ** ** - - -
32MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.